Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties

Since in vitro studies and a preliminary clinical report suggested the efficacy of chloroquine for COVID-19-associated pneumonia, there is increasing interest in this old antimalarial drug. In this article, we discuss the pharmacokinetics and safety of chloroquine that should be considered in light...

Descripción completa

Detalles Bibliográficos
Autores principales: Smit, Cornelis, Peeters, Mariska Y. M., van den Anker, John N., Knibbe, Catherijne A. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165255/
https://www.ncbi.nlm.nih.gov/pubmed/32306288
http://dx.doi.org/10.1007/s40262-020-00891-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165255/
https://www.ncbi.nlm.nih.gov/pubmed/32306288
http://dx.doi.org/10.1007/s40262-020-00891-1

Ejemplares similares